Geron Shareholder Sues Execs Over Drug Launch Claims
A shareholder of Geron Corp. has filed a derivative suit against current and former members of the biopharmaceutical company's top brass, accusing them of making misleading statements about the commercial prospects...To view the full article, register now.
Already a subscriber? Click here to view full article